Learn More
Medchemexpress LLC (+)-JNJ-A07 | 2135640-93-4 | 98.5% | 578.96 | 25 MG

Supplier: Medchemexpress LLC 25MGHY139602
(+)-JNJ-A07 is a highly potent, orally active pan-serotype dengue virus inhibitor that targets the NS3-NS4B interaction. It demonstrates nanomolar to picomolar activity against a panel of 21 clinical isolates. The compound possesses a favorable pharmacokinetic profile, leading to outstanding efficacy against dengue virus infection in mouse infection models.
- Exhibits a high barrier to resistance
- Prevents the formation of the viral replication complex by blocking the interaction between two viral proteins (NS3 and NS4B)
- Potent and orally active pan-serotype dengue virus inhibitor
- Effective against a panel of 21 clinical isolates
- Favorable pharmacokinetic profile
- Outstanding efficacy against dengue virus infection in mouse models
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.